Right ventricular dyssynchrony for the prediction of prognosis in patients with systemic lupus erythematosus-aaociated pulmonary arterial hypertension: a study with two-dimensional speckle tracking
- PMID: 38461202
- DOI: 10.1007/s10554-024-03047-5
Right ventricular dyssynchrony for the prediction of prognosis in patients with systemic lupus erythematosus-aaociated pulmonary arterial hypertension: a study with two-dimensional speckle tracking
Abstract
Pulmonary arterial hypertension (PAH) is a common complication of systemic lupus erythematosus (SLE), and PAH can cause right ventricle (RV) remodel and dyssynchrony. The aim of this study was to explore the value of RV dyssynchrony in predicting adverse clinical events in patients with systemic lupus erythematosus-aaociated pulmonary arterial hypertension (SLE-PAH) using two-dimensional speckle tracking echocardiography (2D-STE). A total of 53 patients with SLE-PAH were enrolled in this study. The dyssynchrony of the RV (RV-SD6) was evaluated by 2D-STE. The clinical data of all participants were collected, and routine cardiac function parameters were measured by two-dimensional echocardiography, and analyzed for their correlation with RV-SD6. The predictive value of RV-SD6 in clinical adverse event was evaluated. RV-SD6 was negatively correlated with RV-FLS, RV-FAC, and TAPSE (r = - 0.788, r = - 0.363 and r = - 0.325, respectively, all P < 0.01), while the correlation with RV-FLS was the strongest. linear regression analysis showed that RV-FLS was an independent risk factor for RV-SD6 (β = - 1.40, 95% CI - 1.65 ~ - 1.14, P < 0.001). Cox regression analysis showed that RV-SD6 was a predictor with clinical adverse events (HR = 1.03, 95% CI 1 ~ 1.06, P < 0.05). RV-SD6 was highly discriminative in predicting clinical adverse events (AUC = 0.764), at a cutoff of 51.10 ms with a sensitivity of 83.3% and specificity of 68.3%. RV-FLS was negatively correlated with RV-SD6 and was an independent risk factor for it. RV-SD6 can serve as an indicator for predicting the occurrence of adverse clinical events in SLE-PAH patients, with high sensitivity and specificity.
Keywords: Clinical adverse events; Pulmonary hypertension; Right ventricular dyssynchrony; Systemic lupus erythematosus; Two-dimensional speckle tracking echocardiography.
© 2024. The Author(s), under exclusive licence to Springer Nature B.V.
Similar articles
-
The Evaluation of Right Ventricular Synchrony by Two-Dimensional Speckle Tracking Echocardiography in Connective Tissue Disease-Associated Pulmonary Arterial Hypertension.Echocardiography. 2025 Jan;42(1):e70060. doi: 10.1111/echo.70060. Echocardiography. 2025. PMID: 39739978
-
Right ventricular-pulmonary arterial coupling ratio derived from 3-dimensional echocardiography predicts outcomes in systemic lupus erythematosus-associated pulmonary arterial hypertension patients.Lupus. 2024 Feb;33(2):155-165. doi: 10.1177/09612033231226352. Epub 2024 Jan 5. Lupus. 2024. PMID: 38182135
-
Right ventricular dyssynchrony predicts clinical outcomes in patients with pulmonary hypertension.Int J Cardiol. 2017 Feb 1;228:912-918. doi: 10.1016/j.ijcard.2016.11.244. Epub 2016 Nov 14. Int J Cardiol. 2017. PMID: 27912199
-
Noninvasive Assessment of Right Ventricular Function in Patients with Pulmonary Arterial Hypertension and Left Ventricular Assist Device.Curr Cardiol Rep. 2019 Jul 5;21(8):82. doi: 10.1007/s11886-019-1156-2. Curr Cardiol Rep. 2019. PMID: 31278558 Review.
-
Cardiorenal Syndrome in Right Heart Failure Due to Pulmonary Arterial Hypertension-The Right Ventricle as a Therapeutic Target to Improve Renal Function.Cardiovasc Drugs Ther. 2025 Apr;39(2):373-384. doi: 10.1007/s10557-024-07588-8. Epub 2024 Jun 7. Cardiovasc Drugs Ther. 2025. PMID: 38847906 Review.
References
-
- Fanouriakis A, Tziolos N, Bertsias G, Boumpas DT (2021) Update omicronn the diagnosis and management of systemic lupus erythematosus. Ann Rheum Dis 80(1):14–25. https://doi.org/10.1136/annrheumdis-2020-218272 - DOI - PubMed
-
- Wang H, Wang Q, Tian Z, Guo X, Lai J, Li M et al (2019) Right ventricular function is associated with quality of life in patients with systemic lupus erythematosus associated pulmonary arterial hypertension. Heart Lung Circ 28(11):1655–1663. https://doi.org/10.1016/j.hlc.2018.09.002 - DOI - PubMed
-
- Tian J, Zhang D, Yao X, Huang Y, Lu Q (2023) Global epidemiology of systemic lupus erythematosus: a comprehensive systematic analysis and modelling study. Ann Rheum Dis 82(3):351–356. https://doi.org/10.1136/ard-2022-223035 - DOI - PubMed
-
- Qian J, Li M, Zhang X, Wang Q, Zhao J, Tian Z et al (2019) Long-term prognosis of patients with systemic lupus erythematosus-associated pulmonary arterial hypertension: CSTAR-PAH cohort study. Eur Respir J. https://doi.org/10.1183/13993003.00081-2018 - DOI - PubMed
-
- Inampudi C, Tedford RJ, Hemnes AR, Hansmann G, Bogaard HJ, Koestenberger M et al (2020) Treatment of right ventricular dysfunction and heart failure in pulmonary arterial hypertension. Cardiovasc Diagn Ther 10(5):1659–1674. https://doi.org/10.21037/cdt-20-348 - DOI - PubMed - PMC
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials